<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: trials</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>New report describes types of research conducted at academic medical centers</title>
   	 <description>A study from the Massachusetts General Hospital (MGH) Institute for Health Policy gives the first detailed look at the types of research currently being conducted within U.S. academic medical centers - medical schools and their affiliated hospitals.  The report in the Sept. 2 Journal of the American Medical Association describes how the traditional way of categorizing life-science researchers as either basic or applied clinical investigators does not adequately reflect the reality of today's academic medical research.</description>
     <link>http://www.physorg.com/news171044651.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 01 Sep 2009 17:37:10 EST</pubDate>
	 <guid isPermaLink="false">news171044651</guid>
</item>
<item>
     <title>Researchers aim to stretch limited supply of flu vaccine</title>
   	 <description>Worried there won't be enough of the swine flu vaccine? Stanford University researchers are beginning clinical trials to determine if vaccines for the swine flu virus, also known as H1N1, could be stretched by lowering the dosage and coupling it with a booster.</description>
     <link>http://www.physorg.com/news171007567.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 01 Sep 2009 07:40:01 EST</pubDate>
	 <guid isPermaLink="false">news171007567</guid>
</item>
<item>
     <title>Telemonitoring: A bridge to personalized medicine</title>
   	 <description>An increasing number of heart failure patients are treated with a number of complex devices, i.e. cardiac resynchronization therapy (CRT).  Recently completed and ongoing clinical trials such as MADIT-CRT and EchoCRT provide evidence of a growing number of CRT patients, in need of individualised treatment. Rising demand for implantable cardiac devices and the simultaneous need for increased efficiency as well as enhanced patient comfort and safety significantly increase the need for remote monitoring technology.</description>
     <link>http://www.physorg.com/news171007694.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 01 Sep 2009 07:20:01 EST</pubDate>
	 <guid isPermaLink="false">news171007694</guid>
</item>
<item>
     <title>Cornell makes cancer vaccine for clinical use</title>
   	 <description>The Bioproduction Facility at Cornell University has produced the first batch of NY-ESO-1 recombinant protein -a cancer vaccine -that will be used in clinical trials for patients facing either ovarian cancer or melanoma.  The facility was developed as a partnership between The Ludwig Institute for Cancer Research and Cornell University.</description>
     <link>http://www.physorg.com/news170013469.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 20 Aug 2009 19:20:01 EST</pubDate>
	 <guid isPermaLink="false">news170013469</guid>
</item>
<item>
     <title>Study shows carvedilol is effective in preventing variceal bleeding in cirrhotic patients</title>
   	 <description>Patients with cirrhosis are at risk for developing portal hypertension that can lead to the formation, dilation, and rupture of esophageal varices.  The annual incidence of esophageal varices is approximately 5% and one third of those will bleed.</description>
     <link>http://www.physorg.com/news169898284.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 19 Aug 2009 11:10:03 EST</pubDate>
	 <guid isPermaLink="false">news169898284</guid>
</item>
<item>
     <title>Britain's first swine-flu trials under way</title>
   	 <description>Britain's first swine flu vaccine trials, led by the University of Leicester and University Hospitals of Leicester NHS Trust, are taking place at the Leicester Royal Infirmary.</description>
     <link>http://www.physorg.com/news169209153.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 11 Aug 2009 11:33:17 EST</pubDate>
	 <guid isPermaLink="false">news169209153</guid>
</item>
<item>
     <title>Cost-effectiveness of cetuximab in metastatic colorectal cancer</title>
   	 <description>From a health-care system perspective, it may be more efficient to use the drug cetuximab only in colorectal cancer patients whose tumors have a wild-type KRAS gene, according to a study published online August 7 in the Journal of the National Cancer Institute.</description>
     <link>http://www.physorg.com/news168929397.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sat, 08 Aug 2009 05:50:31 EST</pubDate>
	 <guid isPermaLink="false">news168929397</guid>
</item>
<item>
     <title>Sanofi Pasteur starts testing swine flu vaccine</title>
   	 <description>(AP) --  French drugmaker Sanofi Pasteur says it has started human trials of its swine flu vaccine in about 2,000 people in the United States.</description>
     <link>http://www.physorg.com/news168849919.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 07 Aug 2009 07:45:46 EST</pubDate>
	 <guid isPermaLink="false">news168849919</guid>
</item>
<item>
     <title>New lab test offers better prediction of HIV microbicide safety</title>
   	 <description>Scientists at Albert Einstein College of Medicine of Yeshiva University have devised a laboratory test for predicting whether microbicides against HIV are safe for human use. The researchers have also discovered why several supposedly "safe" microbicides made women more susceptible to HIV infection. The study appears today in the online version of the Journal of Infectious Disease.</description>
     <link>http://www.physorg.com/news166441689.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 10 Jul 2009 10:48:40 EST</pubDate>
	 <guid isPermaLink="false">news166441689</guid>
</item>
<item>
     <title>Research: Improving treatment of patients with heart attack</title>
   	 <description>When faced with patients suffering a heart attack, doctors have two choices: inject them with medication to dissolve the blood clot (fibrinolytic therapy) or insert a small balloon to open the blocked artery (primary percutaneous coronary intervention (PCI)). </description>
     <link>http://www.physorg.com/news165150274.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 25 Jun 2009 12:30:01 EST</pubDate>
	 <guid isPermaLink="false">news165150274</guid>
</item>
<item>
     <title>The power of prayer?</title>
   	 <description>Health and religion have always been intertwined, most obviously through prayer on behalf of the sick. Does intercessory prayer for sick people actually help heal them? For thousands of years some people have believed so. But new Brandeis University research in the Journal of Religion this month shows that over the last four decades, medical studies of intercessory prayer -the prayer of strangers at a distance -actually say more about the scientists conducting the studies than about the power of prayer to heal.</description>
     <link>http://www.physorg.com/news164471135.html</link>
	 <category>Other Sciences</category>
	 <pubDate>Wed, 17 Jun 2009 16:10:02 EST</pubDate>
	 <guid isPermaLink="false">news164471135</guid>
</item>
<item>
     <title>Analysis of drug-eluting stents data demonstrates safety, efficacy in on-and-off-label use</title>
   	 <description>The Cardiovascular Research Foundation (CRF) announced that results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) were published online June 15 in the journal Circulation. The study also compared the rates of myocardial infarction (MI) and target vessel revascularization (TVR).</description>
     <link>http://www.physorg.com/news164376550.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 16 Jun 2009 13:09:37 EST</pubDate>
	 <guid isPermaLink="false">news164376550</guid>
</item>
<item>
     <title>Brain-computer interface, developed at Brown, begins new clinical trial</title>
   	 <description>BrainGate, an investigational technology being developed to detect brain signals and to allow people with paralysis to use those signals to control assistive devices, is about to begin a second, larger clinical trial. The system is based on neuroscience, engineering and computer science research at Brown University.</description>
     <link>http://www.physorg.com/news163835209.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 10 Jun 2009 06:47:10 EST</pubDate>
	 <guid isPermaLink="false">news163835209</guid>
</item>
<item>
     <title>Women under-represented in most cancer research</title>
   	 <description>Women continue to be under-enrolled in cancer clinical trials, according to a new review, published in the July 15, 2009 issue of CANCER. The study's results suggest that greater efforts are needed to ensure that oncologists know the true effects of treatments and medical procedures in female patients.</description>
     <link>http://www.physorg.com/news163644964.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 08 Jun 2009 01:56:45 EST</pubDate>
	 <guid isPermaLink="false">news163644964</guid>
</item>
<item>
     <title>Cancer Researchers Identify New Mutant Genes</title>
   	 <description>(PhysOrg.com) -- University of New Mexico Cancer Center researchers have identified a genetic mutation underlying one of the most common childhood cancers, acute lymphoblastic leukemia (ALL). The discovery could lead to more effective treatments for a subset of ALL patients who experience minimal benefit with current therapies by using drugs that are already in clinical trials for similar blood diseases in adults. </description>
     <link>http://www.physorg.com/news163263827.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 03 Jun 2009 16:04:46 EST</pubDate>
	 <guid isPermaLink="false">news163263827</guid>
</item>
<item>
     <title>Hybrid remotely operated vehicle 'Nereus' reaches deepest part of the ocean</title>
   	 <description>A new type of deep-sea robotic vehicle called Nereus has successfully reached the deepest part of the world's ocean, reports a team of U.S. engineers and scientists aboard the research vessel Kilo Moana. The dive to 10,902 meters (6.8 miles) occurred on May 31, 2009, at the Challenger Deep in the Mariana Trench in the western Pacific Ocean.</description>
     <link>http://www.physorg.com/news163167519.html</link>
	 <category>Space &amp; Earth</category>
	 <pubDate>Tue, 02 Jun 2009 13:19:47 EST</pubDate>
	 <guid isPermaLink="false">news163167519</guid>
</item>
<item>
     <title>Benefit of aspirin for healthy people is uncertain</title>
   	 <description>(PhysOrg.com) -- A new study has shown that, while taking aspirin is beneficial in preventing heart attacks and strokes among people with established cardiovascular disease (secondary prevention), its benefits don`t clearly outweigh the risks in healthy people (primary prevention).</description>
     <link>http://www.physorg.com/news162820199.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 29 May 2009 12:50:37 EST</pubDate>
	 <guid isPermaLink="false">news162820199</guid>
</item>
<item>
     <title>One in ten advanced colon cancer patients worry about prescription drug costs</title>
   	 <description>The vast majority of advanced colon cancer patients in a clinical trial were not concerned about the cost of prescription drugs for managing chemotherapy side effects, such as infection, pain and nausea and few adopted strategies to reduce drug cost burdens after joining the clinical trial, according to a study led by researchers at Dana-Farber Cancer Institute in Boston. Although few patients reported substantial worry about drug costs, still fewer reported discussing drug cost issues with their physicians, suggesting there are opportunities for improving how physicians integrate discussions about drug costs into clinical practice.</description>
     <link>http://www.physorg.com/news162812925.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 29 May 2009 10:49:06 EST</pubDate>
	 <guid isPermaLink="false">news162812925</guid>
</item>
<item>
     <title>Prescribing sunshine for multiple sclerosis?</title>
   	 <description>Could a holiday in the sun reduce the risk of developing multiple sclerosis? In a recent review for F1000 Medicine Reports, Bridget Bagert and Dennis Bourdette highlight recent advances in potential treatments.</description>
     <link>http://www.physorg.com/news162553554.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 26 May 2009 10:46:17 EST</pubDate>
	 <guid isPermaLink="false">news162553554</guid>
</item>
<item>
     <title>New stem cell research unlocks unknown therapies</title>
   	 <description>New treatments for the devastating Parkinson's disease and ALS are in clinical studies in Sweden, thanks to breaking new stem cell research. This news was presented today by Dr. Jonas Frisen, Professor of stem cell research at Karolinska Institutet, at the world's largest biotech convention, BIO 2009 in Atlanta.</description>
     <link>http://www.physorg.com/news162130324.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 21 May 2009 13:12:49 EST</pubDate>
	 <guid isPermaLink="false">news162130324</guid>
</item>
<item>
     <title>Couples to rely on male contraceptive for new trial</title>
   	 <description>(PhysOrg.com) -- Couples are being asked to replace their usual form of birth control with a new male contraceptive in a study to test its effectiveness.</description>
     <link>http://www.physorg.com/news162053568.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 20 May 2009 15:53:40 EST</pubDate>
	 <guid isPermaLink="false">news162053568</guid>
</item>
<item>
     <title>Novel therapy may prove effective in treatment of 30 percent of cancers</title>
   	 <description>A ground-breaking Canada-wide clinical trial led by Dr. Katherine Borden, at the Institute for Research in Immunology and Cancer (IRIC) of the Universit&amp;eacute; de Montr&amp;eacute;al, has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients. Published in the journal Blood (First Edition), the study demonstrates that ribavirin suppresses the activities of the eIF4E gene in patients. This gene is dysregulated in 30 percent of cancers including breast, prostate, head and neck, colon and stomach cancer.</description>
     <link>http://www.physorg.com/news161454431.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 13 May 2009 17:27:29 EST</pubDate>
	 <guid isPermaLink="false">news161454431</guid>
</item>
<item>
     <title>Compounds in spinal fluid associated with faster decline among individuals with mild dementia</title>
   	 <description>Levels of biomarkers in the cerebrospinal fluid of individuals with very mild dementia may be associated with the rate at which their thinking, learning and memory skills decline, according to a report in the May issue of Archives of Neurology.</description>
     <link>http://www.physorg.com/news161278742.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 11 May 2009 16:39:25 EST</pubDate>
	 <guid isPermaLink="false">news161278742</guid>
</item>
<item>
     <title>Protein effects of hormone replacement therapy uncovered</title>
   	 <description>An in-depth proteomic analysis of the sera of 50 participants from the Women's Health Initiative (WHI) hormone replacement therapy trial provides some explanations for the trial's clinical results. The study, published in Biomed Central's open access journal Genome Medicine, shows that estrogen upregulates proteins involved in several major body processes.</description>
     <link>http://www.physorg.com/news160213500.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 29 Apr 2009 08:47:37 EST</pubDate>
	 <guid isPermaLink="false">news160213500</guid>
</item>
<item>
     <title>Anti-aging cosmetic reduced wrinkles in clinical trial</title>
   	 <description>Scientists testing a cosmetic anti-ageing product sold on the high street have shown it can clinically reduce wrinkles and improve the appearance of skin damaged by everyday exposure to sunlight.</description>
     <link>http://www.physorg.com/news160144292.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 28 Apr 2009 13:32:18 EST</pubDate>
	 <guid isPermaLink="false">news160144292</guid>
</item>
<item>
     <title>Virtual nurse helps counsel patients before their hospital release</title>
   	 <description>(PhysOrg.com) -- Looking for a nurse with a calm, patient bedside manner?</description>
     <link>http://www.physorg.com/news159724733.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 23 Apr 2009 16:59:21 EST</pubDate>
	 <guid isPermaLink="false">news159724733</guid>
</item>
<item>
     <title>Male circumcision reduces HIV risk: No further evidence needed</title>
   	 <description>Three recent African trials support male circumcision for reducing the risk of contracting HIV in heterosexual men. After including new data from these trials in their review, Cochrane Researchers have changed their previous conclusions that there was insufficient evidence to recommend circumcision as an intervention to prevent HIV infection in heterosexual men.</description>
     <link>http://www.physorg.com/news158992038.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 15 Apr 2009 05:27:55 EST</pubDate>
	 <guid isPermaLink="false">news158992038</guid>
</item>
<item>
     <title>Mice and men should have more in common in clinical trials</title>
   	 <description>Just as no two humans are the same, a Purdue University scientist has shown treating mice more as individuals in laboratory testing cuts down on erroneous results and could significantly reduce the cost of drug development.</description>
     <link>http://www.physorg.com/news157643106.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 30 Mar 2009 14:45:34 EST</pubDate>
	 <guid isPermaLink="false">news157643106</guid>
</item>
<item>
     <title>Hormone Relaxine helps treat heart failure: study</title>
   	 <description> Relaxine, a naturally occurring hormone that helps women adapt to pregnancy, is showing promise as a treatment for acute heart failure, a new study has found. </description>
     <link>http://www.physorg.com/news157616798.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 30 Mar 2009 07:27:51 EST</pubDate>
	 <guid isPermaLink="false">news157616798</guid>
</item>
<item>
     <title>Vaccine against CMV shows promise in clinical trial</title>
   	 <description>A new vaccine has the potential to be the first to prevent maternal and congenital cytomegalovirus (CMV) infection, according to a University of Alabama at Birmingham (UAB) study published in the March 19 edition of the New England Journal of Medicine. </description>
     <link>http://www.physorg.com/news156615651.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 18 Mar 2009 17:21:22 EST</pubDate>
	 <guid isPermaLink="false">news156615651</guid>
</item>


</channel>
</rss>

